Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 611-260-5 | CAS number: 55349-01-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
- Endpoint:
- basic toxicokinetics, other
- Type of information:
- other: expert statement
- Adequacy of study:
- supporting study
- Reliability:
- other: expert statement
- Rationale for reliability incl. deficiencies:
- other: No studies are available on toxicokinetics, metabolism and distribution of WS406658. Predictions were made based on physical-chemical properties and information from toxicological studies performed with the read-across source substance.
- Executive summary:
No specific study was performed on absorption, distribution, metabolism and/or excretion (ADME) of WS406658. Predictions on the toxicokinetic behaviour were made based on physical-chemical properties and information from toxicological studies. These data were obtained by read-across from the read-across source substance WS405777.As outlined in the „Validity Assessment Report“ for the read-across approach (see IUCLID Section 13.2) read-across from testing data obtained with the UVCB substance WS405777 is considered appropriate for the safety evaluation as well as classification and labelling of the mono-constituent substance WS406658 based on the close chemical similarity between the two substances.
WS406658 is a mono-constituent substance with a purity of > 99% (w/w). The main constituent is a saturated C42compound with the molecular formula C42H84N2O4. The substance contains two amide bonds and two non-terminal and non-vicinal hydroxyl groups as the only functional groups. The following data on physical chemical properties of WS406658 are the basis for this toxicokinetics assessment.
- Molecular weight: 681 Da
- Water solubility: < 1 mg/l (determined with the r-a source substance); 2.3 x 10-9mg/l (calculated by US EPA WSKOWWIN)
- Melting point: 133°-138°C; substance decomposes before boiling (>250°C)
- Octanol/water partition coefficient: log Pow> 6 (determined with the r-a source substance);
log Pow= 12.3 (calculated by US EPA KOWWIN)
- Vapour pressure: 2 x 10-6Pa (determined with the r-a source substance)In all toxicological tests performed according to Annexes VII and VIII of the REACH Regulation with the read-across source substance no adverse effects were observed up to the highest doses required to be tested according to the relevant guidelines.
The ECHA “Guidance on information requirements and chemical safety assessment Chapter R.7c: Endpoint specific guidance, 2014” document provides guidance, which physico-chemical properties commonly determine dermal, oral, and inhalatory absorption of substances.
Bioavailability of WS406658 in general is expected to be very limited, because of the relatively high molecular weight, very low water solubility and high lipohilicity of the substance.
Accordingly, systemic availability of WS406658 after topical administration is expected to be very limited. Also systemic availability of WS406658 after oral administration is expected to be very limited. In toxicity studies with single or repeated oral exposure to the read-across source substance no effects were observed. Availability of WS406658 under a vapour state is unlikely, because of its low vapour pressure.
Based on the available data on WS406658 and the read-across source substance the bioacumulation potential of WS406658 cannot be judged. However, based on the physical-chemical properties systemic availability of WS406658 via dermal, oral and inhalation exposure is expected to be very low. Also the bioaccumulation potential is expected to be very low based on the relatively high molecular weight and the very high octanol/water partition coefficient of the substance.
Conclusion
While toxicokinetic data is not available on WS406658, based on the properties of the substance and based on the favourable toxicological testing results obtained with the read-across source substance the target substance WS406658 is expected to be hardly bioavailable. Bioaccumulation is not expected. Further information on distribution, metabolism or excretion is not available.
Reference
Description of key information
No specific study was performed on absorption, distribution, metabolism and/or excretion (ADME) of WS406658. Its systemic availability after topical or oral administration is expected to be very limited based on its relatively high molecular weight, low water solubility and high lipohilicity restricting the bioavailability of the substance. Availability of WS406658 under a vapour state is unlikely, because of its low vapour pressure.
Based on the available data the bioacumulation potential cannot be judged. However, based on the very low dermal, oral and inhalative bioavailability of the substance and absence of adverse effects in all toxicological tests performed with the read-across source substance a low bioaccumulation potential (if any) is expected.
Key value for chemical safety assessment
Additional information
No specific study was performed on absorption, distribution, metabolism and/or excretion (ADME) of WS406658. Predictions on the toxicokinetic behaviour were made based on physical-chemical properties and information from toxicological studies. These data were obtained by read-across from the read-across source substance WS405777.As outlined in the „Validity Assessment Report“ for the read-across approach (see IUCLID Section 13.2) read-across from testing data obtained with the UVCB substance WS405777 is considered appropriate for the safety evaluation as well as classification and labelling of the mono-constituent substance WS406658 based on the close chemical similarity between the two substances.
WS406658 is a mono-constituent substance with a purity of > 99% (w/w). The main constituent is a saturated C42compound with the molecular formula C42H84N2O4. The substance contains two amide bonds and two non-terminal and non-vicinal hydroxyl groups as the only functional groups. The following data on physical chemical properties of WS406658 are the basis for this toxicokinetics assessment.
- Molecular weight: 681 Da
- Water solubility: < 1 mg/l (determined with the r-a source substance);
2.3 x 10-9mg/l (calculated by US EPA WSKOWWIN)
- Melting point: 133°-138°C; substance decomposes before boiling (>250°C)
- Octanol/water partition coefficient: log Pow> 6 (determined
with the r-a source substance);
log Pow= 12.3 (calculated by US EPA KOWWIN)
- Vapour pressure: 2 x 10-6Pa (determined with the r-a source
substance)
In all toxicological tests performed according to Annexes VII and VIII of the REACH Regulation with the read-across source substance no adverse effects were observed up to the highest doses required to be tested according to the relevant guidelines.
The ECHA “Guidance on information requirements and chemical safety assessment Chapter R.7c: Endpoint specific guidance, 2014” document provides guidance, which physico-chemical properties commonly determine dermal, oral, and inhalatory absorption of substances.
Bioavailability of WS406658 in general is expected to be very limited, because of the relatively high molecular weight, very low water solubility and high lipohilicity of the substance.
Accordingly, systemic availability of WS406658 after topical administration is expected to be very limited.
Also systemic availability of WS406658 after oral administration is expected to be very limited. In toxicity studies with single or repeated oral exposure to the read-across source substance no effects were observed.
Availability of WS406658 under a vapour state is unlikely, because of its low vapour pressure.
Based on the available data on WS406658 and the read-across source substance the bioacumulation potential of WS406658 cannot be judged. However, based on the physical-chemical properties systemic availability of WS406658 via dermal, oral and inhalation exposure is expected to be very low. Also the bioaccumulation potential is expected to be very low based on the relatively high molecular weight and the very high octanol/water partition coefficient of the substance.
Conclusion
While toxicokinetic data is not available on WS406658, based on the properties of the substance and based on the favourable toxicological testing results obtained with the read-across source substance the target substance WS406658 is expected to be hardly bioavailable. Bioaccumulation is not expected. Further information on distribution, metabolism or excretion is not available.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.